This sexually transmitted infection is almost entirely preventable. Here's what experts say you really need to know to ...
Nearly invisible and deceptively thin, this ice is one of winter’s deadliest hazards. Here’s how it forms and why it causes ...
Evolutionarily speaking, the ultimate goal of a lifeform is to reproduce and stave off extinction. Many plants and animals ...
Measles, which was declared to be eliminated in 2000 in the United States, has seen a resurgence, with more than 2,000 cases ...
A skin infection has many signs that are often ignored. Here are the ones to watch out for and when to seek medical treatment ...
Stripe is a payment service provider that accepts credit cards, digital wallets and many other payment methods. Many, or all, of the products featured on this page are from our advertising partners ...
InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.
In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...
TipRanks on MSN
InflaRx reveals phase 3 post‑hoc efficacy signals for vilobelimab in pyoderma gangrenosum after trial halt
InflaRx ( ($IFRX) ) has shared an announcement. On December 30, 2025, InflaRx reported detailed Phase 3 data analyses for vilobelimab in pyoderma ...
InflaRx (IFRX) outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum, which was terminated earlier this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results